Role of bone morphogenetic protein receptors in the development of pulmonary arterial hypertension

Advances in Experimental Medicine and Biology

Volumn 661, Issue , 2010, Pages 251-264

  Morrell, Nicholas W ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Bone morphogenetic proteins; Genetics; Pulmonary hypertension; Signal transduction; Vascular biology

Indexed keywords

BONE MORPHOGENETIC PROTEIN RECEPTOR; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; PROSTACYCLIN; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

CONFERENCE PAPER; ENDOTHELIAL DYSFUNCTION; ENZYME INHIBITION; FAMILIAL DISEASE; GENE MUTATION; HUMAN; MOLECULAR GENETICS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PULMONARY HYPERTENSION; SIGNAL TRANSDUCTION; TISSUE DIFFERENTIATION; ANIMAL; GENETICS; HEART VENTRICLE REMODELING; METABOLISM; MUTATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; HUMANS; HYPERTENSION, PULMONARY; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; SIGNAL TRANSDUCTION; SMAD PROTEINS; VENTRICULAR REMODELING;

EID: 77951217443     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60761-500-2_16     Document Type: Conference Paper

References (69)

1. Loyd JE, Primm RK, Newman JH (1984) Familial primary pulmonary hypertension: clinical patterns. Am Rev Respir Dis 129:194-197 (Pubitemid 14176528)
2. Newman JH, Wheeler L, Lane KB et al (2001) Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred. N Engl J Med 345:319-324 (Pubitemid 32703234)
3. Newman JH, Trembath RC, Morse JA et al (2004) Genetic basis of pulmonary arterial hypertension: current understanding and future directions. J Am Coll Cardiol 43:S33-S39
4. Nichols WC, Koller DL, Slovis B et al (1997) Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31-32. Nat Genet 15:277-280 (Pubitemid 27098722)
5. The International PPH Consortium, Lane KB, Machado RD, Pauciulo MW et al (2000) Heterozygous germ-line mutations in BMPR2, encoding a TGF-b receptor, cause familial primary pulmonary hypertension. Nat Genet 26:81-84
6. Deng Z, Morse JH, Slager SL et al (2000) Familial primary pulmonary hypertension (Gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet 67:737-744 (Pubitemid 30659603)
7. Machado RD, Aldred MA, James V et al (2006) Mutations of the TGF-b type II receptor BMPR2 in pulmonary arterial hypertension. Hum Mut 27:121-132 (Pubitemid 43238027)
8. Thomson JR, Machado RD, Pauciulo MW et al (2000) Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-b family. J Med Genet 37:741-745
9. Aldred M, Vijayakrishnan J, James V et al (2006) BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension. Hum Mut 27:212-213
10. Cogan JD, Vnencak-Jones CL, Phillips JA et al (2005) Gross BMPR2 gene rearrangements constitute a new cause for primary pulmonary hypertension. Genet Med 7:169-174 (Pubitemid 40478153)
11. Miyazono K, Maeda S, Imamura T. (2005) BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev 16:251-263 (Pubitemid 40910315)
12. Kawabata M, Imamura T, Miyazano K (1998) Signal transduction by bone morphogenetic proteins. Cytokine Growth Factor Rev 9:49-61 (Pubitemid 28280536)
13. Massagué J, Chen Y-G (2000) Controlling TGF-b signaling. Genes Dev 14:627-644
14. Attisano L, Wrana JL (2002) Signal transduction by the TGF-b superfamily. Science 296:1646-1647
15. Rosenzweig BL, Imamura T, Okadome T et al (1995) Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci U S A 92:7632-7636
16. Ishikawa T, Yoshioka H, Ohuchi H, Noji S, Nohno T (1995) Truncated type II receptor for BMP-4 induces secondary axial structures in Xenopus embryos. Biochem Biophys Res Commun 216:26-33
17. Howe JR, Bair JL, Sayed MG et al (2001) Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet 28:184-187 (Pubitemid 32538067)
18. Lehmann K, Seemann P, Stricker S et al (2003) Mutations in bone morphogenetic protein receptor 1B cause brachydactyly type A2. Proc Natl Acad Sci U S A 100:12277-12282 (Pubitemid 37271551)
19. Nickel J, Kotzsch A, Sebald W, Mueller TD (2005) A single residue of GDF-5 defines binding specificity to BMP receptor IB. J Mol Biol 349:933-947 (Pubitemid 40779617)
20. David L, Mallet C, Mazerbourg S, Feige JJ, Bailly S (2007) Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood 109:1953-1961 (Pubitemid 46348192)
21. David L, Mallet C, Keramidas M et al (2008) Bone morphogenetic protein-9 is a circulating vascular quiescence factor. Circ Res 102:914-922 (Pubitemid 351591550)
22. Massagué J, Seoane J, Wotton D (2005) Smad transcription factors. Genes Dev 19:2783-2810 (Pubitemid 41739965)
23. Shi W, Chen H, Sun J, Chen C, Zhao J, Wang YL et al (2004) Overexpression of Smurf1 negatively regulates mouse embryonic lung branching morphogenesis by specifically reducing Smad1 and Smad5 proteins. Am J Physiol Lung Cell Mol Physiol 286:L293-L300 (Pubitemid 38129510)
24. Chen HB, Shen J, Ip YT, Xu L (2006) Identification of phosphatases for Smad in the BMP/ DPP pathway. Genes Dev 20:648-653
25. Nohe A, Keating E, Knaus P, Petersen NO (2004) Signal transduction of bone morphogenetic protein receptors. Cell Signal 16:291-299 (Pubitemid 37542404)
26. Massagué J (2003) Integration of Smad and MAPK pathways: a link and a linker revisited. Genes Dev 17:2993-2997 (Pubitemid 38040762)
27. Grimm OH, Gurdon JB (2002) Nuclear exclusion of Smad2 is a mechanism leading to loss of competence. Nat Cell Biol 4:519-522 (Pubitemid 34752438)
28. Kretzschmar M, Doody J, Massagu J (1997) Opposing BMP and EGF signalling pathways converge on the TGF-b family mediator Smad1. Nature 389:618-622 (Pubitemid 27446181)
29. Rudarakanchana N, Flanagan JA, Chen H et al (2002) Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension. Hum Mol Genet 11:1517-1525 (Pubitemid 34679252)
30. Nishihara A, Watabe T, Imamura T, Miyazono K (2002) Functional heterogeneity of bone morphogenetic protein receptor-II mutants found in patients with primary pulmonary hypertension. Mol Biol Cell 13:3055-3063 (Pubitemid 35034245)
31. Sobolewski A, Rudarakanchana N, Upton PD et al (2008) Failure of bone morphogenetic protein receptor trafficking in pulmonary arterial hypertension: potential for rescue. Hum Mol Genet 17:3180-3190
32. Yu PB, Beppu H, Kawai N, Li E, Bloch KD (2005) Bone morphogenetic protein (BMP) type II receptor deletion reveals BMP ligand-specific gain of signaling in pulmonary artery smooth muscle cells. J Biol Chem 280:24443-24450 (Pubitemid 40934529)
33. Long L, MacLean MR, Jeffery TK et al (2006) Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice. Circ Res 98:818-827
34. Morrell NW, Yang X, Upton PD et al (2001) Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-b1 and bone morphogenetic proteins. Circulation 104:790-795 (Pubitemid 32762677)
35. Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, ten Dijke P (2002) Balancing the activation status of the endothelium via two distinct TGF-b receptors. EMBO J 21:1743-1753 (Pubitemid 34614630)
36. Goumans MJ, Valdimarsdottir G, Itoh S et al (2003) Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFb/ALK5 signaling. Mol Cell 12:817-828 (Pubitemid 37352776)
37. Itoh S, Thorikay M, Kowanetz M et al (2003) Elucidation of Smad requirement in transforming growth factor-b type I receptor-induced responses. J Biol Chem 278:3751-3761 (Pubitemid 36801101)
38. Atkinson C, Stewart S, Upton PD et al (2002) Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor. Circulation 105:1672-1678 (Pubitemid 34298611)
39. Du L, Sullivan CC, Chu D et al (2003) Signaling molecules in nonfamilial pulmonary hypertension. N Engl J Med 348:500-509 (Pubitemid 36159885)
40. Caldwell RL, Gadipatti R, Lane KB, Shepherd VL (2005) HIV-1 TAT represses transcription of the bone morphogenic protein receptor-2 in U937 monocytic cells. J Leukoc Biol 79:192-201
41. Hu H, Sung A, Zhao G et al (2006) Simvastatin enhances bone morphogenetic protein receptor type II expression. Biochem Biophys Res Commun 339:59-64 (Pubitemid 41697514)
42. Yang X, Long L, Southwood M et al (2005) Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension. Circ Res 96:1053-1063 (Pubitemid 40791377)
43. Rondelet B, Kerbaul F, Van Beneden R et al (2005) Prevention of pulmonary vascular remodeling and of decreased BMPR-2 expression by losartan therapy in shunt-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol 289:H2319-H2324 (Pubitemid 41698538)
44. Takahashi H, Goto N, Kojima Y et al (2006) Downregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 290:L450-L458 (Pubitemid 43725089)
45. Richter A, Yeager ME, Zaiman A, Cool CD, Voelkel NF, Tuder RM (2004) Impaired transforming growth factor-b signaling in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 170:1340-1348 (Pubitemid 39657199)
46. Botney MD, Bahadori L, Gold LI (1994) Vascular remodelling in primary pulmonary hypertension: potential role for transforming growth factor-beta. Am J Pathol 144:286-295 (Pubitemid 24165949)
47. Zhang S, Fantozzi I, Tigno DD et al (2003) Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 285:L740-L754 (Pubitemid 37022876)
48. Yang J, Davies RJ, Southwood M et al (2008) Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension. Circ Res 102:1212-1221
49. Valdimarsdottir G, Goumans MJ, Rosendahl A et al (2002) Stimulation of Id1 expression by bone morphogenetic protein is sufficient and necessary for bone morphogenetic proteininduced activation of endothelial cells. Circulation 106:2263-2270 (Pubitemid 35222223)
50. Teichert-Kuliszewska K, Kutryk MJB, Kuliszewski MA et al (2006) Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension. Circ Res 98:209-217
51. Beppu H, Kawabata M, Hamamoto T et al (2000) BMP type II receptor is required for gastrulation and early development of mouse embryos. Dev Biol 221:249-258 (Pubitemid 30253588)
52. Yang X, Castilla LH, Xin X et al (1999) Angiogenesis defects and mesenchymal apoptosis in mice lacking smad5. Development 126:1571-1580 (Pubitemid 29204322)
53. Beppu H, Ichinose F, Kawai N et al (2004) BMPR-II heterozygous mice have mild pulmonary hypertension and an impaired pulmonary vascular remodeling response to prolonged hypoxia. Am J Physiol Lung Cell Mol Physiol 287:L1241-L1247 (Pubitemid 39507203)
54. Song Y, Jones JE, Beppu H, Keaney JF Jr, Loscalzo J, Zhang YY (2005) Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice. Circulation 112:553-562 (Pubitemid 41060796)
55. Miyaki M, Iijima T, Konishi M et al (1999) Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis. Oncogene 18:3098-3103 (Pubitemid 29261230)
56. West J, Fagan K, Steudel W et al (2004) Pulmonary hypertension in transgenic mice expressing a dominant-negative BMPRII gene in smooth muscle. Circ Res 94:1109-1114 (Pubitemid 38579706)
57. Delot EC, Bahamonde ME, Zhao M, Lyons KM (2003) BMP signaling is required for septation of the outflow tract of the mammalian heart. Development 130:209-220 (Pubitemid 36113956)
58. Roberts KE, McElroy JJ, Wong WPK et al (2004) BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease. Eur Respir J 24:371-374 (Pubitemid 39232257)
59. Hong K-H, Lee YJ, Lee E et al (2008) Genetic ablation of the Bmpr2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension. Circulation 118:722-730
60. McMurtry MS, Moudgil R, Hashimoto K, Bonnet S, Michelakis ED, Archer SL (2007) Overexpression of human bone morphogenetic protein receptor 2 does not ameliorate monocrotaline pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 292:L872-L878 (Pubitemid 46608233)
61. Reynolds AM, Xia W, Holmes MD et al (2007) Bone morphogenetic protein type 2 receptor gene therapy attenuates hypoxic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 292:L1182-L1192 (Pubitemid 47084862)
62. Willette RN, Gu JL, Lysko PG, Anderson KM, Minehart H, Yue T (1999) BMP-2 gene expression and effects on human vascular smooth muscle cells. J Vasc Res 36:120-125 (Pubitemid 29210918)
63. Nakaoka T, Gonda K, Ogita T et al (1997) Inhibition of rat vascular smooth muscle proliferation in vitro and in vivo by bone morphogenetic protein-2. J Clin Invest 100:2824-2832 (Pubitemid 28007552)
64. Zeisberg M, Hanai Ji, Sugimoto H et al (2003) BMP-7 counteracts TGF-b1-induced epithelialto- mesenchymal transition and reverses chronic renal injury. Nat Med 9:964-968 (Pubitemid 36889942)
65. Morrissey J, Hruska K, Guo G, Wang S, Chen Q, Klahr S (2002) Bone morphogenetic protein- 7 improves renal fibrosis and accelerates the return of renal function. J Am Soc Nephrol 13:S14-S21
66. Saika S, Ikeda K, Yamanaka O et al (2006) Adenoviral gene transfer of BMP-7, Id2, or Id3 suppresses injury-induced epithelial-to-mesenchymal transition of lens epithelium in mice. Am J Physiol Cell Physiol 290:C282-C289
67. Buckley S, Shi W, Driscoll B, Ferrario A, Anderson K, Warburton D (2004) BMP4 signaling induces senescence and modulates the oncogenic phenotype of A549 lung adenocarcinoma cells. Am J Physiol Lung Cell Mol Physiol 286:L81-L86 (Pubitemid 38055861)
68. Warburton D, Bellusci S (2004) The molecular genetics of lung morphogenesis and injury repair. Paediatr Respir Rev 5:S283-S287
69. Long L, Crosby AC, Yang X et al (2009) Altered BMP/TGF-b signaling in rat models of pulmonary hypertension: potential for ALK-5 inhibition in prevention and progression of disease. Circulation (in press)